Remedium Lifecare Enhances R&D and CDMO, Secures ?182.7 Crore Export Deal
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Supha Pharmachem Ltd on 6ix
Earlier from Supha Pharmachem
- Supha Pharmachem Ltd Press Release May 08 2025
- Supha Pharmachem Ltd Press Release May 05 2025
- Supha Pharmachem Ltd Press Release Apr 28 2025
- Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Later from Supha Pharmachem
- Board Meeting Outcome for Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended.
- Supha Pharmachem Ltd Press Release May 22 2025
- Board Meeting Intimation for Meeting Scheduled To Be Held On 30.05.2025.
- Supha Pharmachem Ltd Press Release May 27 2025
- Compliances-Reg.24(A)-Annual Secretarial Compliance
Follow Supha Pharmachem into a list and get an email when it puts out news.
Follow Supha Pharmachem